<h4>Purpose</h4>Epidermal growth factor receptor (EGFR) mutations related to gefitinib responsiveness in non-small cell lung cancer have been found recently. Detection of EGFR mutations has become an important issue for therapeutic decision-making in non-small cell lung cancer.<h4>Experimental desig...
No comments yet
Be the first to share your thoughts!